Jake Taylor-King
Co-Founder and Chief Innovation Officer at Relation
Prior to co-founding Relation Therapeutics, Jake Taylor-King was an academic and industry researcher interested in company formation at the intersection of technology, computation, and the clinic. Previously an award-winning mathematician (G-Research prize, Lee Segel Prize), he has degrees from the University of Bristol (BSc), the University of Oxford (MSc, D.Phil), and the University of Cambridge (MPhil). Jake completed his postdoctoral work at the ETH Zürich in single-cell bioinformatics, focusing on integrating his mathematical knowledge with next generation experimental techniques. Jake previously worked as Head of Bioinformatics at Empyrean Therapeutics, designing and optimising high throughput CRISPR screens.
Visit website: https://www.relationrx.com/about/jake-taylor-king
See alsoDetails last updated 12-Sep-2025
Jake Taylor-King is also referenced in the following:
Accelerating Healthy Longevity: From Code to Clinic
25-Sep-2025
This event celebrates the full spectrum of longevity and how it’s shaping the future of wellness, population health and our cities (London, UK)